Abstract:Clostridium difficile (C.difficile) is an exclusively anaerobic, spore-forming, and Gram-positive pathogen that is the most common cause of nosocomial diarrhea and is becoming increasingly prevalent in the community. Because C. difficile is strictly anaerobic, spores that can survive for months in the external environment contribute to the persistence and diffusion of C. difficile within the healthcare environment and community. Antimicrobial therapy disrupts the natural intestinal flora, allowing spores to develop into propagules that colonize the colon and produce toxins, thus leading to antibiotic-associated diarrhea and pseudomembranous enteritis. However, there is no licensed vaccine to prevent Clostridium difficile infection (CDI). In this study, a multi-epitope vaccine was designed using modern computer methods. Two target proteins, CdeC, affecting spore germination, and fliD, affecting propagule colonization, were chosen to construct the vaccine so that it could simultaneously induce the immune response against two different forms (spore and propagule) of C. difficile. We obtained the protein sequences from the National Center for Biotechnology Information (NCBI) database. After the layers of filtration, 5 cytotoxic T-cell lymphocyte (CTL) epitopes, 5 helper T lymphocyte (HTL) epitopes, and 7 B-cell linear epitopes were finally selected for vaccine construction. Then, to enhance the immunogenicity of the designed vaccine, an adjuvant was added to construct the vaccine. The Prabi and RaptorX servers were used to predict the vaccine’s two- and three-dimensional (3D) structures, respectively. Additionally, we refined and validated the structures of the vaccine construct. Molecular docking and molecular dynamics (MD) simulation were performed to check the interaction model of the vaccine–Toll-like receptor (TLR) complexes, vaccine–major histocompatibility complex (MHC) complexes, and vaccine–B-cell receptor (BCR) complex. Furthermore, immune stimulation, population coverage, and in silico molecular cloning were also conducted. The foregoing findings suggest that the final formulated vaccine is promising against the pathogen, but more researchers are needed to verify it.

Large Clostridial Toxins: A Brief Review and Insights into Antigen Design for Veterinary Vaccine Development

Vaccine Production to Protect Animals Against Pathogenic Clostridia

Potential Protective Immunogenicity of Recombinant Clostridium Perfringens Α–β2–β1 Fusion Toxin in Mice, Sows and Cows

In silico vaccine design: Targeting highly epitopic regions of Clostridium perfringens type D epsilon toxin and Clostridium novyi type B alpha toxin for optimal immunogenicity

A novel approach to generate a recombinant toxoid vaccine against Clostridium difficile

In Silico Vaccine Design: Targeting Highly Epitopic Regions of Type D Epsilon Toxin and Type B Alpha Toxin for Optimal Immunogenicity

A Chimeric Toxin Vaccine Protects Against Primary and Recurrent Clostridium Difficile Infection

Review of advances in molecular structure and biological function of alpha toxin of Clostridium perfringens

An EGFP-marked Recombinant Lactobacillus Oral Tetravalent Vaccine Constitutively Expressing Α, Ε, Β1, and Β2 Toxoids for Clostridium Perfringens Elicits Effective Anti-Toxins Protective Immunity.

Immunogenicity of a pentavalent recombinant Escherichiacoli bacterin against enterotoxemia and botulism in sheep

Progress and Challenges in Vaccine Development Against Enterotoxigenic Escherichia Coli (Etec)-Associated Porcine Post- Weaning Diarrhoea (PWD)

Design and characterization of a multi-epitope vaccine against Clostridium botulinum A3 Loch Maree intoxication in humans

Clostridium perfringens antigens and challenges for development of vaccines against necrotic enteritis in poultry

Using reverse vaccinology techniques combined with B-cell epitope prediction to screen potential antigenic proteins of the bovine pathogen Clostridium perfringens type A

Development of Multi-epitope Mrna Vaccine Against Clostridioides Difficile Using Reverse Vaccinology and Immunoinformatics Approaches

In Situ Capture of Bacterial Toxins for Antivirulence Vaccination

Immunoinformatics Approach Toward the Introduction of a Novel Multi-Epitope Vaccine Against Clostridium Difficile

Development of two recombinant vaccines against Clostridioides difficile infection and immunogenicity in pregnant sows and neonatal piglets

Exploring the Toxin-Mediated Mechanisms in Clostridioides difficile Infection

Progress on β2 Toxin of Clostridium Perfringens

Proteomic Profiling of Precipitated Clostridioides Difficile Toxin A and B Antibodies.